Cellular Immunotherapy for Neuroblastoma: A Review of Current Vaccine and Adoptive T Cell Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|4|424-429

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.4, 2009-02, pp. : 424-429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imaging Adoptive Cell Transfer Based Cancer Immunotherapy

By  

Current Pharmaceutical Biotechnology, Vol. 11, Iss. 6, 2010-09 ,pp. : 672-684

Bentham Science Publishers

Access to resources Recommend Favorite

Genetically Redirected T Lymphocytes for Adoptive Immunotherapy of Solid Tumors

By  

Current Gene Therapy, Vol. 14, Iss. 1, 2014-02 ,pp. : 52-62

Bentham Science Publishers

Access to resources Recommend Favorite

Improvement of Adoptive Cellular Immunotherapy of Human Cancer Using Ex-Vivo Gene Transfer

By  

Current Gene Therapy, Vol. 2, Iss. 1, 2002-02 ,pp. : 91-100

Bentham Science Publishers

Access to resources Recommend Favorite

Life or Death of T Cells with Antigen-Specific Receptors - Using T Cells for Cancer Adoptive Immunotherapy / Gene Therapy

By  

Current Gene Therapy, Vol. 1, Iss. 3, 2001-09 ,pp. : 253-255

Bentham Science Publishers

Access to resources Recommend Favorite

The Recombinant T Cell Receptor Strategy: Insights into Structure and Function of Recombinant Immunoreceptors on the Way Towards an Optimal Receptor Design for Cellular Immunotherapy

By  

Current Gene Therapy, Vol. 2, Iss. 2, 2002-05 ,pp. : 211-226

Bentham Science Publishers

Access to resources Recommend Favorite